Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Details for Australian Patent Application No. 2004283059 (hide)

Owner Watson Pharmaceuticals, Inc.

Inventors Cardinal, John; Nangia, Avinash; Kositprapa, Unchalee; Goldfarb, Robert I.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004283059

PCT Pub. Number WO2005/039540

Priority 10/664,803 19.09.03 US

Filing date 12 February 2004

Wipo publication date 6 May 2005

Acceptance publication date 10 February 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/425 (2006.01) - Thiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/039540 Priority application(s): WO2005/039540

10 February 2011 Application Accepted

  Published as AU-B-2004283059

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283065-Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

2004283056-Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds